These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1704065)

  • 61. Inhibition of HIV-1 in cell culture by synthetic humate analogues derived from hydroquinone: mechanism of inhibition.
    Schneider J; Weis R; Männer C; Kary B; Werner A; Seubert BJ; Riede UN
    Virology; 1996 Apr; 218(2):389-95. PubMed ID: 8610466
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potent inhibition of human immunodeficiency virus by MDL 101028, a novel sulphonic acid polymer.
    Taylor DL; Brennan TM; Bridges CG; Mullins MJ; Tyms AS; Jackson R; Cardin AD
    Antiviral Res; 1995 Oct; 28(2):159-73. PubMed ID: 8585769
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues.
    Golebiewski WM; Keyes RF; Cushman M
    Bioorg Med Chem; 1996 Oct; 4(10):1637-48. PubMed ID: 8931933
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and inhibitory activities of isochromophilone analogues against gp120-CD4 binding.
    Sun XL; Takayanagi H; Matsuzaki K; Tanaka H; Furuhata K; Omura S
    J Antibiot (Tokyo); 1996 Jul; 49(7):689-92. PubMed ID: 8784432
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors.
    Buckheit RW; Hartman TL; Watson KM; Kwon HS; Lee SH; Lee JW; Kang DW; Chung SG; Cho EH
    Antivir Chem Chemother; 2007; 18(5):259-75. PubMed ID: 18046959
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potent HIV-1 protease inhibitors with antiviral activities in vitro.
    Sham HL; Betebenner DA; Wideburg NE; Saldivar AC; Kohlbrenner WE; Vasavanonda S; Kempf DJ; Norbeck DW; Zhao C; Clement JJ
    Biochem Biophys Res Commun; 1991 Mar; 175(3):914-9. PubMed ID: 2025263
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-HIV-1 activity and structure-activity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope.
    Lian W; Wu M; Huang N; Gao N; Xiao C; Li Z; Zhang Z; Zheng Y; Peng W; Zhao J
    Biochim Biophys Acta; 2013 Oct; 1830(10):4681-91. PubMed ID: 23769857
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
    Miyasaka T; Tanaka H; Baba M; Hayakawa H; Walker RT; Balzarini J; De Clercq E
    J Med Chem; 1989 Dec; 32(12):2507-9. PubMed ID: 2479745
    [No Abstract]   [Full Text] [Related]  

  • 70. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
    Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
    J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
    Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
    J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparison of human immunodeficiency virus type 1 inhibition by partially purified aqueous extracts of Chinese medicinal herbs.
    Collins RA; Ng TB; Fong WP; Wan CC; Yeung HW
    Life Sci; 1997; 60(23):PL345-51. PubMed ID: 9180371
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
    Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
    J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and anti-HIV activity of 10,11-dihydropyrrolo [1,2-b][1,2,5]benzothiadiazepine-11-acetic acid 5,5-dioxide derivatives and related compounds.
    Silvestri R; Artico M; Pagnozzi E; Stefancich G; Massa S; La Colla P; Loi AG; Spiga MG; Corrias S; Lichino D
    Farmaco; 1996 Jun; 51(6):425-30. PubMed ID: 8766226
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein.
    Este JA; Schols D; De Vreese K; Van Laethem K; Vandamme AM; Desmyter J; De Clercq E
    Mol Pharmacol; 1997 Jul; 52(1):98-104. PubMed ID: 9224818
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The synthesis of nucleoside 5'-O-(1,1-dithiotriphosphates).
    Okruszek A; Olesiak M; Balzarini J
    J Med Chem; 1994 Oct; 37(22):3850-4. PubMed ID: 7525960
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rational design of peptide-based HIV proteinase inhibitors.
    Roberts NA; Martin JA; Kinchington D; Broadhurst AV; Craig JC; Duncan IB; Galpin SA; Handa BK; Kay J; Kröhn A
    Science; 1990 Apr; 248(4953):358-61. PubMed ID: 2183354
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anti-HIV activity of a series of cosalane amino acid conjugates.
    Santhosh KC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2505-8. PubMed ID: 11086716
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interaction of aurintricarboxylic acid (ATA) with four nucleic acid binding proteins DNase I, RNase A, reverse transcriptase and Taq polymerase.
    Ghosh U; Giri K; Bhattacharyya NP
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Dec; 74(5):1145-51. PubMed ID: 19836295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.